• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

REMICADE

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Hepatitis and Autoimmune Diseases Drugs

August 24, 2018Autoimmune Diseases, Hepatitis, Vizit Graphs
Hepatitis and Autoimmune Diseases Drugs

Managing infections and autoimmunity with Remicade and Ribavirin. Explore the live graph.

Vizit Graphs Tag Cloud

INFLAMMATION IL17A CASP3 CANCER IL6 ANGIOGENESIS CELL DIFFERENTIATION CANDIDA ALBICANS LISTERIA MONOCYTOGENES IL23A PORPHYROMONAS GINGIVALIS IMMUNE RESPONSE TH17 CELLS DIABETES MELLITUS CELL DIVISION METFORMIN STREPTOCOCCUS PNEUMONIAE CD4 IFNG RHEUMATOID ARTHRITIS BREAST CANCER CELL DEATH REMICADE HELICOBACTER PYLORI CTLA4 CLOSTRIDIUM DIFFICILE CELL PROLIFERATION STAPHYLOCOCCUS AUREUS PARKINSON DISEASE APOPTOTIC PROCESS PSEUDOMONAS AERUGINOSA TNF ALZHEIMER'S DISEASE INSULIN RECEPTOR SOD1 ESCHERICHIA COLI TP53 AGING 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE NEURODEGENERATIVE DISORDERS DOXORUBICIN ERBB-2 FOXP3 AUTOPHAGY

© 2020 Biovista Vizit All Rights Reserved.